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Abstract
Background: Due to increasing resistance development among bacteria, antimicrobial peptides (AMPs), are receiving
increased attention. Ideally, AMP should display high bactericidal potency, but low toxicity against (human) eukaryotic cells.
Additionally, short and proteolytically stable AMPs are desired to maximize bioavailability and therapeutic versatility.
Methodology and Principal Findings: A facile approach is demonstrated for reaching high potency of ultra-short
antimicrobal peptides through end-tagging with W and F stretches. Focusing on a peptide derived from kininogen,
KNKGKKNGKH (KNK10) and truncations thereof, end-tagging resulted in enhanced bactericidal effect against Gram-negative
Escherichia coli and Gram-positive Staphylococcus aureus. Through end-tagging, potency and salt resistance could be
maintained down to 4–7 amino acids in the hydrophilic template peptide. Although tagging resulted in increased
eukaryotic cell permeabilization at low ionic strength, the latter was insignificant at physiological ionic strength and in the
presence of serum. Quantitatively, the most potent peptides investigated displayed bactericidal effects comparable to, or in
excess of, that of the benchmark antimicrobial peptide LL-37. The higher bactericidal potency of the tagged peptides
correlated to a higher degree of binding to bacteria, and resulting bacterial wall rupture. Analogously, tagging enhanced
peptide-induced rupture of liposomes, particularly anionic ones. Additionally, end-tagging facilitated binding to bacterial
lipopolysaccharide, both effects probably contributing to the selectivity displayed by these peptides between bacteria and
eukaryotic cells. Importantly, W-tagging resulted in peptides with maintained stability against proteolytic degradation by
human leukocyte elastase, as well as staphylococcal aureolysin and V8 proteinase. The biological relevance of these findings
was demonstrated ex vivo for pig skin infected by S. aureus and E. coli.
Conclusions/Significance: End-tagging by hydrophobic amino acid stretches may be employed to enhance bactericidal
potency also of ultra-short AMPs at maintained limited toxicity. The approach is of general applicability, and facilitates
straightforward synthesis of hydrophobically modified AMPs without the need for post-peptide synthesis modifications.
Citation: Pasupuleti M, Schmidtchen A, Chalupka A, Ringstad L, Malmsten M (2009) End-Tagging of Ultra-Short Antimicrobial Peptides by W/F Stretches to
Facilitate Bacterial Killing. PLoS ONE 4(4): e5285. doi:10.1371/journal.pone.0005285
Editor: Alfredo Herrera-Estrella, Cinvestav, Mexico
Received December 1, 2008; Accepted March 24, 2009; Published April 17, 2009
Copyright:  2009 Pasupuleti et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Swedish Research Council (projects 13471 and 621-2003-4022), the Royal Physiographic Society in Lund,
the Welander-Finsen, Soderberg, Schyberg, Crafoord, Alfred Osterlund, and Kock Foundations, DermaGen AB, and The Swedish Government Funds for Clinical
Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Martin Malmsten and Artur Schmidtchen are co-founders, and members of the Board, of DermaGen AB, which develops antimicrobial
peptide therapeutics for commercial purposes.
* E-mail: martin.malmsten@farmaci.uu.se
Introduction
Due to increasing resistance development among bacteria,
antimicrobial peptides (AMPs), are currently receiving increased
attention [1–7]. Ideally, AMP should display high bactericidal
potency, but low toxicity against (human) eukaryotic cells.
Approaches to reach such selectivity include QSAR in combina-
tion with directed amino acid modifications, as well as identifica-
tion of AMPs of endogenous origin [8–19]. Since bacterial
membrane rupture is a key mechanism of action of these peptides,
AMPs should bind to, and rupture, bacterial membranes but not
eukaryotic membranes. Due to bacterial membranes being
cholesterol-void and dominated by anionic phospholipids, whereas
(human) eukaryotic membranes contain cholesterol and are
dominated by zwitterionic ones, some AMP binding selectivity
can be obtained for positively charged and hydrophilic AMPs [20].
However, the electrostatic surface potential of S. aureus and some
other common pathogens is frequently limited, and may be
reduced or even reversed, e.g., by L-lysine modification of
phosphatidylglycerol, D-alanine modification of cell wall teichoic
acid, and aminoarabinose modifications in LPS, all precluding
AMP binding [4]. Additionally, electrostatically driven peptide
binding is salt sensitive, and bactericidal potency of such peptides
at physiological ionic strength limited. This situation can be
remedied by increasing the hydrophobicity of AMPs, although
AMPs of higher hydrophobicity have been found to be less
selective in their action, and to display increased toxicity [21].
Given the above, and inspired by lipopeptides [22–27], we
previously identified end-tagging of AMPs with hydrophobic
amino acid stretches as a facile and readily tunable approach to
achieve high adsorption of partially submerged, highly charged
AMPs [28]. Such end-tagged peptides were found to display
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spectrum, also at physiological ionic strength and in the presence
of serum, as well as ex vivo and in vivo. From detailed physico-
chemical investigations, involving studies on peptide adsorption at
supported lipid bilayers, peptide-induced liposome rupture, both
as a function of peptide sequence, electrolyte concentration, and
lipid membrane composition, as well as LPS-binding experiments,
circular dichroism experiments on peptide conformation, and
studies on bacterial wall rupture, it was concluded that the end-
tagged peptides reach their potency and salt resistance through the
hydrophobic end-tags promoting peptide adsorption at phospho-
lipid membranes. The selectivity between bacteria and eukaryotic
cells could also be explained on a mechanistic level, and due to the
lower charge density of eukaryotic cell membrane, combined with
the presence of cholesterol in the latter. Through the membrane-
condensing effect of cholesterol, incorporation of bulky end-tags
(shown to take place in the polar headgroup region of the
phospholipid membrane) is precluded, resulting in lower mem-
brane incorporation and rupture, and contributing to the
selectivity observed between bacteria and eukaryotic cells.
In the present study, we bring this work further by investigating
whether tagging by hydrophobic amino acid stretches may be
employed to enhance bactericidal potency also of ultra-short
AMPs at maintained limited toxicity. This is a key aspect for the
wider therapeutic use of AMPs, since the macromolecular nature
of AMPs, typically containing 20–40 amino acids, limits their use
through administration routes other than the topical and
parenteral ones, and precludes their biological uptake, e.g., by
the gastrointestinal, nasal, transdermal, and pulmonary routes.
This precludes the wider pharmaceutical applicability of longer
AMPs. If AMP potency and selectivity can be retained for shorter
peptides, on the other hand, a range of potential new indications
for AMP therapies opens up related to their higher and wider
bioavailability [29].
Materials and Methods
Peptides
The high quality peptides used in this work were synthesized
by Biopeptide Co., San Diego, USA, with the exception of LL-
37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES),
which was obtained from Innovagen AB, Lund, Sweden. The
purity (.95%) of these peptides was confirmed by mass spectral
analysis (MALDI-ToF Voyager), provided by the suppliers.
Peptides for the initial screening were from Sigma-Genosys
(Sigma-Aldrich, St. Louis, USA), generated by a peptide synthesis
platform (PEPscreenH, Custom Peptide Libraries, Sigma Genosys)
with a yield of ,1–6 mg. MALDI-ToF Mass Spectrometry was
performed on these peptides, and average crude purity found to be
60–70%. Prior to biological testing the PEPscreen peptides were
diluted in H20 (5 mM stock), and stored at 220 C. This stock
solution was used for the subsequent experiments.
Microorganisms
Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC
29213 were obtained from the Department of Clinical Bacteriol-
ogy at Lund University Hospital.
Radial diffusion assay (RDA)
Essentially as described earlier [30,31] bacteria were grown to
mid-logarithmic phase in 10 ml of full-strength (3% w/v) trypti-
case soy broth (TSB) (Becton-Dickinson, Cockeysville, USA). The
microorganisms were then washed once with 10 mM Tris,
pH 7.4. Subsequently, 4610
6 bacterial colony forming units were
added to 15 ml of the underlay agarose gel, consisting of 0.03%
(w/v) TSB, 1% (w/v) low electroendosmosis type (EEO) agarose
(Sigma-Aldrich, St. Louis, USA) and 0.02% (v/v) Tween 20
(Sigma-Aldrich, St. Louis, USA). The underlay was poured into a
Ø 144 mm petri dish. After agarose solidification, 4 mm-diameter
wells were punched and 6 ml of peptide with required concentra-
tion added to each well. Plates were incubated at 37uC for 3 hours
to allow diffusion of the peptides. The underlay gel was then
covered with 15 ml of molten overlay (6% TSB and 1% Low-EEO
agarose in distilled H2O). Antimicrobial activity of a peptide is
visualized as a zone of clearing around each well after 18–24 hours
of incubation at 37uC. Results given represent mean values from
triplicate measurements.
Protease sensitivity assay
Peptides (1 mg) were incubated at 37uC with S. aureus aureolysin
(0.1 mg, 25000 units/mg), S. aureus V8 proteinase (0.1 mg,
2000 mU), both from BioCol GmbH (Potsdam, Germany), or
neutrophil elastase (0.4 mg, 29 units/mg; Calbiochem (La Jolla,
USA)) in a total volume of 30 ml for 3 hours. The materials were
analyzed on 16.5% precast sodium dodecyl sulfate polyacrylamide
(SDS-PAGE) Tris-Tricine gels (BioRad, Hercules, USA) and
analyzed after staining with Coomassie Blue R-250 (Merck,
Darmstadt, Germany).
MTT assay
Sterile filtered MTT (3-(4,5-dimethylthiazolyl)-2,5-diphenyl-
tetrazolium bromide; Sigma-Aldrich, St. Louis, USA) solution
(5 mg/ml in PBS) was stored protected from light at 220uC until
usage. HaCaT keratinocytes, 3000 cells/well, were seeded in 96
well plates and grown in keratinocyte-SFM/BPE-rEGF medium
to confluence. Keratinocyte-SFM/BPE-rEGF medium alone, or
keratinocyte-SFM supplemented with 20% serum, was added,
followed by peptide addition to 60 mM. After incubation over
night, 20 ml of the MTT solution was added to each well and the
plates incubated for 1 h in CO2 at 37uC. The MTT- containing
medium was then removed by aspiration. The blue formazan
product generated was dissolved by the addition of 100 ml of 100%
DMSO per well. The plates were then gently swirled for 10 min at
room temperature to dissolve the precipitate. The absorbance was
monitored at 550 nm, and results given represent mean values
from triplicate measurements.
Lactate dehydrogenase (LDH) assay
HaCaT keratinocytes were grown in 96 well plates (3000 cells/
well) in serum-free keratinocyte medium (SFM) supplemented with
bovine pituitary extract and recombinant EGF (BPE-rEGF)
(Invitrogen, Eugene, USA) to confluency. The medium was then
removed, and 100 ml of the peptides investigated (at 60 mM,
diluted in SFM/BPE-rEGF or in keratinocyte-SFM supplemented
with 20% human serum) added in triplicates to different wells of
the plate. The LDH-based TOX-7 kit (Sigma-Aldrich, St. Louis,
USA) was used for quantification of LDH release from the cells.
Results given represent mean values from triplicate measurements,
and are given as fractional LDH release compared to the positive
control consisting of 1% Triton X-100 (yielding 100% LDH
release).
Hemolysis assay
EDTA-blood was centrifuged at 800 g for 10 min, whereafter
plasma and buffy coat were removed. The erythrocytes were
washed three times and resuspended to 5% in PBS, pH 7.4. For
experiments in 50% blood, EDTA-blood was diluted (1:1) with
Tagging Antimicrobial Peptides
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1 h at 37uC in the presence of peptides (60 mM). 2% Triton X-100
(Sigma-Aldrich, St. Louis, USA) served as positive control. The
samples were then centrifuged at 800 g for 10 min. The
absorbance of hemoglobin release was measured at 540 nm and
is expressed as % of TritonX-100 induced hemolysis. Results given
represent mean values from triplicate measurements.
Slot-blot assay
LPS and heparin binding ability of the peptides were examined
by slot-blot assay. Peptides (1, 2 and 5 mg) were bound to
nitrocellulose membrane (Hybond-C, GE Healthcare BioSciences,
Buckinghamshire, UK), pre-soaked in PBS, by vacuum. For LPS
binding, membranes were then blocked by 2 wt% BSA in PBS,
pH 7.4, for 1 h at RT and subsequently incubated with
radiolabelled LPS (40 mg/mL; 0.13610
6 cpm/mg) for 1 h at RT
in PBS [32]. For heparin binding, the peptide-loaded membrane
was incubated with radiolabelled heparin (10 mg/mL;
0.2610
6 cpm/mg) for 1 h in PBS [33], without prior BSA
blocking. The radioiodination (
125I) of heparin and LPS was
performed as described earlier [32]. After LPS and heparin
binding, the membranes were washed 3 times, 10 min each time,
in PBS and visualized for radioactivity on Bas 2000 radioimaging
system (Fuji, Tokyo, Japan).
Antibacterial effects ex vivo
For evaluating AMPs ex vivo, a pig skin model was used as
previously described [34] but with modifications. Defatted pig
hides were first washed with water and then with 70% ethanol.
They were then destubbled with disposable razors and 868c m
pieces were cut, sealed in plastic wrap, and frozen at 220uC.
Before use, skin samples were thawed, washed with ethanol (70%)
and water. In order to separate the inoculation areas, sterilized
tubings (polyethylene, 9.6 m, NalgeneH VWR 228-0170) were cut
into ,10 mm lengths, and glued onto the skin samples
(cyanoacrylate glue, Henkel, Du ¨sseldorf, Germany). The skin
was infected by adding 1610
6 CFU of an overnight culture of S.
aureus ATCC 29213 and E. coli ATCC 25922 in a total volume of
10 ml. After an incubation time of 4 hours at 37uC, peptide-
containing solutions (1 mM) were applied. Bacterial sampling was
performed after an incubation time of 2 hours by washing the
reaction chambers twice with 250 ml of 10 mM phosphate buffer,
pH 7.4, 0.05wt% Triton X-100, supplemented with 0.1% dextran
sulfate, added to block peptide activity during sampling (average
molecular weight 500 kDa, Sigma-Aldrich, St. Louis, USA).
Results given represent mean values (n=6).
Liposome preparation and leakage assay
The liposomes investigated were either zwitterionic (DOPC) or
anionic (either DOPE/DOPG 75/25 mol/mol or E. coli lipid
extract containing 57.5% phosphatidylethanolamine, 15.1%
phosphatidylglycerol, 9.8% cardiolipin, and 17.6% other lipids).
DOPG (1,2-Dioleoyl-sn-Glycero-3-Phosphoglycerol, monosodium
salt), DOPC (1,2-dioleoyl-sn-Glycero-3-phoshocholine), and
DOPE (1,2-dioleoyl-sn-Glycero-3-phoshoetanolamine) were all
from Avanti Polar Lipids (Alabaster, USA) and of .99% purity.
Due to the long, symmetric and unsaturated acyl chains of the
pure phospholipids, several methodological advantages are
reached. In particular, membrane cohesion is good, facilitating
very stable and unilamellar liposomes (observed from cryo-TEM),
and allowing precise values on leakage to be obtained. The lipid
mixtures were dissolved in chloroform, whereafter the solvent was
removed by evaporation under vacuum overnight. Subsequently,
10 mM Tris buffer, pH 7.4, was added together with 0.1 M
carboxyfluorescein (CF) (Sigma, St. Louis, USA). After hydration,
the lipid mixture was subjected to eight freeze-thaw cycles (not the
E. coli lipid mixture) consisting of freezing in liquid nitrogen and
heating to 60uC. In all cases, unilamellar liposomes of about
Ø140 nm were generated by multiple extrusions through
polycarbonate filters (pore size 100 nm) mounted in a LipoFast
miniextruder (Avestin, Ottawa, Canada) at 22uC. Untrapped CF
was then removed by two subsequent gel filtrations (Sephadex G-
50, GE Healthcare, Uppsala, Sweden) at 22uC, with Tris buffer as
eluent. CF release from the liposomes was determined by
monitoring the emitted fluorescence at 520 nm from a liposome
dispersion (10 mM lipid in 10 mM Tris, pH 7.4). An absolute
leakage scale was obtained by disrupting the liposomes at the end
of each experiment through addition of 0.8 mM Triton X-100
(Sigma-Aldrich, St. Louis, USA). A SPEX-fluorolog 1650 0.22-m
double spectrometer (SPEX Industries, Edison, USA) was used for
the liposome leakage assay. Measurements were performed in
triplicate at 37uC.
Statistics
Values are reported as means6standard deviation of the means.
To determine significance, analysis of variance with ANOVA
(SigmaStat, SPSS Inc., Chicago, USA), followed by post hoc testing
using the Holm-Sidak method, was used as indicated in the figure
legends, where ‘‘n’’ denotes number of independent experiments.
Significance was accepted at p,0.05.
Results
As an initial step, effects of W-tag length, as well as hydrophilic
peptide length and composition, on the bactericidal potency were
investigated by RDA for Gram-negative E. coli and Gram-positive
S. aureus. For both bacteria, tagging of KNK10 by either WWW or
WWWWW significantly increases bactericidal potency, also at
high ionic strength (Figure 1A). Truncating KNK10 from either
C- or N-terminus results in a decrease in both bactericidal potency
and salt resistance, although very short peptides are reached in
both series (KNK5-WWW, KNK4-WWWWW, and KNG5-
WWW, respectively) before significant reduction in bactericidal
potency is observed at low ionic strength. At high ionic strength,
substantial bactericidal potency was observed for the longer
WWWWW tag down to KNK7-WWWWW. The WWW tag, on
the other hand, is too short to provide bactericidal potency at high
ionic strength when combined with the short hydrophilic peptide
stretches.
Bactericidal potency was probed also for selected peptides of
high purity: KNK7, KNK10, KNK7-WWWWW, and KNK10-
WWWWW (Figure 1B). Neither non-tagged KNK7 nor KNK10
displayed substantial bactericidal activity against E. coli and S.
aureus. End-tagging either of these peptides with WWWWW, on
the other hand, resulted in strongly bactericidal peptides against
both E. coli and S. aureus, also at high ionic strength. Quantitatively,
the bacterial killing is more potent for KNK10-WWWWW than
for KNK7-WWW, with bactericidal potency comparable to that
of the benchmark peptide LL-37. Similar effects were found also
for F-tagged peptides (Figure S1A).
The non-tagged peptides show no hemolysis above that of the
negative control (Figure 1 and Figure 2. Tagging with WWW
results in little, if any, increase in hemolysis, whereas that of the
longer WWWWW results in a slightly increased hemolysis. This
effect is concentration dependent, with hemolysis for KNK10-
WWWWW being comparable to, or lower than, that of LL-37
(Figure 1B). Similarly, tagging with WWWWW, but not WWW,
results in an increased cell permeabilization monitored by MTT
Tagging Antimicrobial Peptides
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the WWWWW-tagged peptide displays no detectable permeabi-
lization with either LDH release or MTT assay (Figure 2). Again,
similar results were obtained for the F-tagged peptides (Figure
S1B).
As can be seen in Figure 3A, the increased bactericidal potency
of the W-tagged peptides correlates to a higher permeabilization of
bacteria. In analogy, results from anionic liposomes composed of
either a bacteria-mimicking lipid mixture (DOPE/DOPG) or lipid
extract from E. coli, showed tagged peptides to be much more
potent in causing membrane rupture and liposome leakage that
the corresponding non-tagged ones (Figure 4A). For both these
lipid mixtures, rapid and extensive leakage induction was observed
with the tagged peptides (Figure 4B). As with bacterial killing,
peptide-induced liposome leakage increased with increasing
peptide concentration and hydrophobic tag length, and was
partially reduced at high ionic strength, the salt inactivation
decreasing with increasing hydrophobic tag length. In analogy to
the bactericidal and cytotoxicity results, liposome leakage
induction by the tagged peptides is substantial for both negatively
charged (‘‘bacterial’’) lipid mixtures investigated, but substantially
lower for zwitterionic (‘‘eukaryotic’’) DOPC liposomes, particu-
larly at high ionic strength. Additionally, W-tagging was found to
facilitate binding of both KNK10 and KNK7 to LPS (and heparin)
also at high ionic strength (Figure 3B), an effect which can be
completely reversed through addition of heparin, acting as an
Figure 1. Antibacterial and hemolytic activity of peptides. (A) Antibacterial activity of PEPscreen peptides as assessed by radial diffusion assay
(RDA) in the presence and absence of 0.15 M NaCl against E. coli ATCC 25922 and S. aureus ATCC 29213, as well as hemolysis. For determination of
antibacterial activity, bacteria (4610
6 cfu/ml) were inoculated in 0.1% TSB agarose gel and 4 mm wells punched. In each well 6 ml of peptide (at
100 mM) was loaded. The zones of clearance correspond to the inhibitory effect of each peptide after incubation at 37uC for 18–24 h (mean values are
presented, n=3). For hemolysis, the cells were incubated with the peptides at 60 mM, while 2% Triton X-100 served as positive control. The
absorbance of hemoglobin release was measured at 540 nm and is expressed as % of Triton X-100 induced hemolysis. (B) Dose dependent activity of
selected high purity peptides KNK10, KNK7, and W-modified variants of these against E. coli ATCC 25922 and S. aureus ATCC 29213 in RDA. Shown
also are effects of the peptides on human erythrocytes in the hemolysis assay. Throughout, mean values are presented, n=3. (In Figure 1B, the
difference between tagged and non-tagged peptides is statistically significant in all cases (P,0.001, two way ANOVA).) WWW tripeptide alone yielded
non-measurable bactericidal effects (0 mm clearance zone in RDA) under the conditions used in Figure 1A, as well as hemolysis (2.360.2%)
comparable to that in the negative control (2.560.05%). Due to poor aqueous solubility, longer oligotryptophan peptides could not be investigated.
doi:10.1371/journal.pone.0005285.g001
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shown).
Since one of the attractive features of KNK10 is its relative
stability against proteolytic degradation, we also investigated if
hydrophobic tagging effected the peptide proteolytic stability.
Similar to KNK10, KNK10-WWWWW displayed good stability
against proteolytic degradation by human leukocyte elastase, as
well as staphylococcal aureolysin and V8 proteinase (Figure 5A).
(Similar results were obtained also with KNK10-FFFFF and
KNK7-WWWWW (results not shown)). In contrast, but in
agreement with previous findings [28,35], LL-37 undergoes
substantial degradation by all these enzymes. From this it is clear
that the tagging can be achieved at maintained proteolytic stability
of the peptide.
S. aereus is a notorious pathogen in relation to a number of skin
infections, including atopic dermatitis, impetigo, and wound
infections [36]. Frequently, the spread of the infection is mediated
by bacterial proteases, which degrade both collagen and non-
collagen host proteins, thus destroying host physical carriers.
Hence, the stability of the end-tagged peptides, notably KNK10-
WWWWW, against a range of proteases, combined with potent
bactericidal effects, could make this peptide a potential candidate
for skin infection therapies. In order to demonstrate this, the effect
of KNK10-WWWWW was investigated in a skin wound model.
For both E. coli, which sometimes contaminates wounds and
causes surgical site infections [37], and S. aureus, KNK10-
WWWWW, but not the non-tagged KNK10, drastically reduced
bacteria viability at the skin surface (Figure 5B, left panel).
Although quantitatively smaller effects were observed deeper down
in the skin, KNK10-WWWWW nevertheless caused significant
reduction of both bacteria investigated, while the non-tagged
KNK10 was much less potent (Figure 5B, right panel).
Figure 2. Effect of peptides on eukaryotic cells. Effects of peptides on HaCaT cells and erythrocytes in absence and presence of 20% human
serum. The MTT-assay (upper panel) was used to measure viability of HaCaT keratinocytes in the presence of KNK10 peptides with variable W tagging.
In the assay, MTT is modified into a dye, blue formazan, by enzymes associated to metabolic activity. The absorbance of the dye was measured at
550 nm. Cell permeabilizing effects of the indicated peptides (middle panel) were measured by the LDH-based TOX-7 kit. Hemolytic effects of the
indicated peptides are also shown (lower panel). Cells were incubated with peptides at 60 mM, while 2% Triton X-100 served as positive control. The
absorbance of hemoglobin release was measured at 540 nm and is expressed as % of Triton X-100 induced hemolysis (mean values are presented,
n=3). (For MTT and LDH, the difference between tagged and non-tagged peptides is statistically significant in the absence of serum (P,0.001, one
way ANOVA), whereas the difference in the presence of serum is not statistically significant. For hemolysis, the difference between tagged and non-
tagged peptides is not statistically significant.)
doi:10.1371/journal.pone.0005285.g002
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Although AMPs influence bacteria in a multitude of ways, e.g.,
DNA binding, enzyme activities, and cell wall synthesis [5], their
main mode of action is defect formation in bacterial walls, notably
its lipid membrane(s) [1–7]. For some peptides, e.g., melittin,
alamethicin, gramicidin A, and magainin 2, this is achieved
through the formation of transmembrane structures, sometimes
associated with induction of an ordered secondary structure,
notably a-helix structures [5,6,38]. For disordered peptides with a
high net charge, membrane distruption is reached by other
mechanisms, e.g., induction of a negative curvature strain,
membrane thinning, or local packing defect formation associated
with peptide localization primarily in the polar headgroup region
of the phospholipids membrane [5,20,39–42]. In the latter case,
defect formation increases with the amount of peptide adsorbed at
the lipid membrane and with the peptide charge [20,39,40].
Although a high positive peptide net charge may result in high
adsorption of AMPs to highly negatively charged bacterial
membranes, electrostatic interactions are screened at high ionic
strength, resulting in reduced driving force for AMP adsorption,
and in partial or complete loss in bactericidal capacity at
physiological conditions. Simultaneously increasing AMP hydro-
phobicity may constitute a strategy for increasing salt resistanse of
AMPs. Although peptides based on overall hydrophobic interac-
tions are less selective between bacterial and eukaryotic lipid
membranes, which risks resulting in an enhanced cytotoxicity of
more hydrophobic AMPs [21], carefully balancing hydrophobicity
and charge in a sequence-specific way may result in short, potent
antimicrobial peptides displaying low mammalian cell toxicity
(e.g., [43]).
Considering this, a general, facile, and tunable platform for
balanced hydrophobic modifications of AMPs is desirable.
Although such hydrophobic modifications can be achieved in a
number of ways, end-tagging by hydrophobic amino acid stretches
is one of the easier ones since it requires no post-synthesis
modification, since it allows the primary AMP sequence to be
retained, as well as maximized interaction between the hydro-
phobic tag and the phospholipid membrane. In addition, end-
tagging does not detrimentally affect proteolytic stability of AMPs
(Figure 5A), a factor of importance for bactericidal potency on S.
aureus, P. aeruginosa and other bacteria excreting proteolytic
enzymes [4].
Particularly W- and F-based ones are interesting as hydrophobic
end-tags. These bulky, aromatic, and polarizable residues have an
affinity to interfaces [44,45], and are frequently located in the
proximity of the polar headgroup region in phospholipids
membranes [46–52]. Through this interaction with the phospho-
lipids membrane, W/F residues are able to act as an anchor for
the peptide, and may similarly be important for the function of
other ultra-short membrane-interacting peptides, such as sub-
stance P [53]. In combination with highly charged AMP
sequences, this results in an effective pinning of a large number
of peptide charges in the polar headgroup region of the
membrane, in turn facilitating membrane defect formation and
rupture. Due to the large size of the W/F groups, combined with
their surface localization, part of the selectivity between bacterial
and eukaryotic cell membranes is obtained through cholesterol
precluding membrane insertion of the W/F groups, and through a
lower adsorption of the cationic composite peptides at zwitterionic
than at anionic membranes [28]. For Gram-negative bacteria, this
phospholipid membrane selectivity is accompanied by selectivity
originating from LPS binding, which is significantly enhanced
through the W tagging. Together, these effects probably
contribute substantially to the selectivity observed with the
presently investigated W/F-tagged peptides, displaying high
bactericidal potency, but at the same time low toxicity.
Numerous previous studies in literature address the issue of
balancing electrostatic and hydrophobic aspects for effective and
selective action of various types of AMPs, including effects of
hydrophobic substitutions. However, with the exception of
lipopeptides, this previous work has concerned specific AMPs,
for which hydrophobicity/charge variations can be said to be
largely sequence-specific. The present work, as well as previous
work in literature on lipopeptides, on the other hand, report on
more generally applicable technology platforms of versatile use for
boosting potency of AMPs. Clearly, the end-tagged peptides are
somewhat related to lipopeptides, consisting of a polar (linear or
cyclic, positively or negatively charged) peptide sequence with a
hydrophobic moiety, e.g., a fatty acid acid, covalently attached.
Lipopeptides, such as polymyxin B and colistin, are potent against
particularly Gram-negative bacteria, but also display substantial
Figure 3. Peptide interaction with bacteria and LPS. (A)
Permeabilizing effects of peptides on bacteria. E. coli was incubated
with KNK7, KNK10, and the indicated W-modified variants (all at 30 mM)
in buffer at physiological salt (0.15 M NaCl) for 2 h at 37uC, after which
permeabilization was assessed using the impermeant probe FITC.
The upper images in each row are Nomarski Differential Interference
Contrast images, while the lower show FITC fluorescence of bacteria. (B)
LPS and heparin binding abilities of the KNK7, KNK10 and the indicated
W-modified variants peptides.
doi:10.1371/journal.pone.0005285.g003
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independent incorporation of acyl groups in a way comparable to
that of peptides of high hydrophobicity [21]. Like antimicrobial
peptides, lipopeptides affect bacteria in a multitude of ways, e.g.,
DNA replication, transcription, and translation, and also exert
anti-endotoxic effects through LPS binding and neutralization.
The latter LPS-binding effect is similar to that of the presently
investigated peptides. Also in analogy to the present findings,
longer acyl chains in such lipopeptides cause increased disruption
of model lipid membranes, as well as activity against bacteria and
fungi [22]. In contrast to lipopeptides containing long acyl chains,
however, which depend on self-assembly for their bactericidal
action, W/F-tags are too short, bulky, and polarizable to cause
peptide self-assembly. This means that no self-assembly takes
place, potentially translating to faster action since no aggregation/
disintegration is needed for peptide action [28]. Of particular
interest in relation to the present work is a recent investigation by
Makovitzki et al., in which ultra-short peptide sequences
conjugated to palmitic acid were studied [54]. In agreement with
the present investigation, very short peptide sequences were found
to be able to reach potency also in the biological context, although
with the potency decreasing for sufficiently short hydrophilic
sequences. Also in agreement with the present investigation, the
antimicrobial effect of these lipopeptides was found to depend on
the detailed sequence of the hydrophilic peptide stretch, and to
involve membrane permeabilization and disintegration. On the
other hand, the authors also observed complex and large self-
assembly structures, largely driven by the long and saturated
palmitoyl chains, which may affect the antimicrobial potency of
these lipopeptides, particularly at temperatures below the melting
temperature of palmitic acid (63–64uC) [55]. In contrast, KNK10-
WWWWW and other end-tagged peptides with smaller mean
hydrophobicities and hydrophobic tag length do not appear to
form aggregates in aqueous solution, determined from end-tag W
fluorescence spectra showing these W-residues to be in a polar
environment (lmax=358 nm; results not shown).
As demonstrated, W/F-tagging is a facile and flexible approach
for reaching increased bactericidal potency for ultra-short AMPs,
without the need for post-peptide-synthesis modification, applica-
ble for both Gram-negative and Gram-positive bacteria. Through
the composition and/or the length of the hydrophilic peptide and/
or the hydrophobic tag, potency and toxicity of the peptide can be
tuned, e.g., depending on the relative need of bactericidal potency
and limited toxicity. As shown in a previous investigation with
longer AMPs, W/F peptide tagging may be applied to a broad
range of AMPs, but particularly so to polar and highly charged
peptides [28]. This flexibility is attractive from a therapeutic
versatility perspective, since it allows one AMP to be further
modified to fit the conditions of the indication at hand. Particularly
for AMPs not sensitive to infection-related proteolytic degradation,
the finding that hydrophobic tagging may be achieved without
affecting proteolytic stability also opens up new avenues in
applications characterized by high proteolytic activity, such as
chronic wounds, eye infections, and cystic fibrosis. The biological
relevance of the ultra-short end-tagged peptides was clearly
demonstrated here in the skin infection model.
In fact, W/F tagging may possibly be employed to enhance the
biological activity of membrane-interacting peptides in a broader
Figure 4. Peptide-mediated permeabilization of liposomes. (A) Effects of KNK10 and indicated W-modified peptides on liposomes in the
presence and absence of 0.15 M NaCl. The membrane permeabilizing effect, and resulting release of carboxyfluorescein from liposomes, was
recorded by fluorescence spectroscopy. Left panel shows DOPC (zwitterionic) liposomes, the center panel DOPE/ DOPG (75/25 mol/mol; anionic)
liposomes, and the right panel (anionic) liposomes formed by E. coli lipids (mean values are presented, n=3). (B) Leakage kinetics on addition of 1 mM
KNK10 and KNK10-WWWWW to DOPE/DOPG (75/25 mol/mol; anionic) liposomes in 10 mM Tris buffer, pH 7.4, with 150 mM NaCl.
doi:10.1371/journal.pone.0005285.g004
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tagging increased the biological potency of short C3a-based
peptides, and that peptide potency increased with an increasing
number of W in the hydrophobic tag [56]. Apart from the effect of
the end-tag on membrane interactions, W-tagging was demon-
strated to promote specific peptide binding to the C3a receptor.
Hence, the binding facility of W-tagged peptides seem to include
not only lipid membranes and LPS, as demonstrated in the present
investigations, but also more specific targets. Given the potency
observed for negatively charged membranes, the end-tagged
peptides may potentially also offer opportunities in other contexts,
e.g., as homing pro-apoptotic peptides [57].
Conclusions
End-tagging by W/F stretches strongly enhances the bacteri-
cidal potency of ultra-short AMPs, even at physiological ionic
strength and in the presence of serum. Hydrophilic peptides as
short as 4–7 amino acids long may thus be rendered potent against
Gram-negative E. coli and Gram-positive S. aureus. Although
toxicity increases with increasing tag length, compositions could be
found at which little or no toxicity is observed, but where the
peptides display high bactericidal potency. In contrast to acyl-
modified lipopeptides, the present approach facilitates straightfor-
ward synthesis of hydrophobically modified AMPs without the
need for post-peptide synthesis modifications. The biological
relevance of the tagged peptides obtained was demonstrated ex
vivo. The tagging, which does not detrimentally affect the
proteolytic stability of the peptides, promotes peptide binding to
bacteria and subsequent wall rupture. Analogously, W-tagging
promotes peptide-induced leakage, particularly in anionic, bacte-
ria-mimicing, liposomes, but also LPS binding, both effects
probably contributing to the selectivity observed between bacteria
and eukaryotic cells.
Supporting Information
Figure S1 Generalization of the concept of end-tagging by
hydrophobic amino acid stretches. Antimicrobial activity as
assessed by radial diffusion assay (RDA) against E. coli ATCC
25922 and S. aureus ATCC 29213 of the indicated peptides in
absence (open bars) or presence (black bars) of 0.15 M NaCl
(mean values are presented, n=3). ‘‘*’’ denotes no clearence zone
detected(A). Effects of peptides on HaCaT cells and erythrocytes
in the presence and absence of human serum. The MTT-assay
(upper panel) was used to measure viability of HaCaT keratino-
cytes in the presence of the indicated peptides. In the assay, MTT
is modified into a dye, blue formazan, by enzymes associated to
metabolic activity. The absorbance of the dye was measured at
550 nm. Cell permeabilizing effects of the indicated peptides
(middle panel) were measured by the LDH-based TOX-7 kit.
Hemolytic effects (lower panel) of the indicated peptides were also
investigated. The cells were incubated with the peptides at
60 mM, while 2% Triton X-100 (Sigma-Aldrich, St. Louis,
USA) served as positive control. The absorbance of hemoglobin
release was measured at 540 nm and is expressed as % of Triton
X-100 induced hemolysis (mean values are presented, n=3) (B).
(For MTT and LDH, the difference between tagged and non-
tagged peptides is statistically significant in the absence of serum
(P,0.001, one way ANOVA), whereas the difference in the
presence of serum is not statistically significant. The difference
between tagged and non-tagged peptides is not statistically
significant regarding hemolysis.)
Found at: doi:10.1371/journal.pone.0005285.s001 (2.88 MB TIF)
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